Fluconazole Use May Raise Risk of Certain Birth Defects

This article originally appeared here.
Share this content:
Fluconazole Use May Raise Risk of Certain Birth Defects
Fluconazole Use May Raise Risk of Certain Birth Defects

THURSDAY, May 5, 2016 (HealthDay News) -- Prenatal use of low-dose fluconazole is associated with cleft lip with cleft palate and d-transposition of the great arteries, according to a study published in the May issue of the American Journal of Obstetrics & Gynecology.

Meredith M. Howley, from the New York State Department of Health in Albany, and colleagues used data from the National Birth Defects Prevention Study to examine the correlation between low-dose fluconazole and the risk of major birth defects. Pregnancies with estimated delivery dated from 1997 to 2011 were included in the study. Information on use of fluconazole in early pregnancy was self-reported for 43,257 mothers (31,645 mothers of birth defect cases and 11,612 mothers of unaffected controls).

The researchers found that 44 case mothers and six control mothers reported using fluconazole. Cleft lip with cleft palate was reported for six exposed infants; atrial septal defects for four infants; and hypospadias, tetralogy of Fallot, d-transposition of the great arteries, and pulmonary vale stenosis for three infants each. Correlations were seen for fluconazole use with cleft lip with cleft palate (odds ratio, 5.53) and d-transposition of the great arteries (odds ratio, 7.56).

"The associations between fluconazole and both cleft lip with cleft palate and d-transposition of the great arteries are consistent with earlier published case reports but not recent epidemiologic studies," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »